Moshav Nir-Banim, Israel

Alon Monsonego

This inventor holds 5 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Ben-Gurion University of the Negev Research and Development Authority, The National Institute for Biotechnology in the Negev Ltd., The Weizmann Institute of Science. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alon Monsonego. Retrieved from https://idiyas.com/inventor/alon-monsonego

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Rehovot, IL (2009)
  • Moshav Nir Banim, IL (2016 - 2021)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Alon Monsonego: Innovator in Modified Cell Technology

Introduction

Alon Monsonego is a notable inventor based in Moshav Nir Banim, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of modified cells. His innovative work has led to the creation of a patent that addresses important aspects of cell signaling.

Latest Patents

Monsonego holds a patent for "Non-cytotoxic modified cells and use thereof." This patent describes modified cells that include a transmembrane polypeptide with at least one extracellular target receptor-binding domain, a transmembrane domain, and an intracellular domain. Notably, the intracellular domain is designed not to transduce any signal. The patent also outlines methods for inducing or inhibiting signaling by a target receptor in a target cell through the use of these modified cells.

Career Highlights

Throughout his career, Alon Monsonego has worked with esteemed organizations such as the National Institute for Biotechnology in the Negev Ltd. and the Ben-Gurion University of the Negev Research and Development Authority. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Monsonego has collaborated with notable colleagues, including Angel Porgador and Roee Atlas. These partnerships have further enriched his research and development efforts in the field of biotechnology.

Conclusion

Alon Monsonego's innovative work in modified cell technology exemplifies the impact of biotechnology on modern science. His patent and collaborations highlight his commitment to advancing research in this vital area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…